HomeProceduresNuclear Medicine (Bone Scan / SPECT)

Nuclear Medicine (Bone Scan / SPECT)

Functional imaging using radioactive tracers — highly sensitive for bone metastases, infection, and thyroid disease.

What Does Nuclear Medicine (Bone Scan / SPECT) Show?

Bone scans use Tc-99m MDP (a bone-seeking radiotracer) to identify areas of increased bone turnover — indicating metastases, infection, fracture, or inflammation. SPECT adds three-dimensional tomographic imaging for better lesion localization. Thyroid nuclear medicine evaluates functional thyroid tissue and ectopic thyroid.

About Nuclear Medicine

⚠️ Uses ionizing radiation (radiotracer)

Nuclear medicine studies involve injecting or inhaling a radioactive tracer (radiopharmaceutical) that travels to specific tissues based on its biochemical properties. A gamma camera detects the radiation emitted by the tracer and generates images showing organ function and physiology — not just anatomy. SPECT adds tomographic reconstruction for improved localisation, and SPECT/CT fuses function with anatomic CT detail.

Radiation & Safety: Nuclear medicine involves administering a radioactive substance internally. Radiation varies by tracer and organ system. Most tracers decay and clear within hours to days. Dose is moderate and comparable to CT for most studies.

When to Use Nuclear Medicine — and When Not To

Choosing the right modality is one of the most impactful parts of the prior authorization process. Payers are more likely to approve a study when the chosen modality is clearly the most appropriate tool for the clinical question.

✓ Nuclear Medicine is the right choice when…

  • Bone metastasis survey: bone scan (Tc-99m MDP) is highly sensitive for metastatic bone disease across the entire skeleton in a single study — superior whole-body bone coverage compared to MRI for cancers that commonly spread to bone (prostate, breast, lung).
  • Functional thyroid evaluation: thyroid scan with radioiodine or Tc-99m identifies hot (hyperfunctioning) vs. cold (non-functioning) nodules — information X-ray, CT, and ultrasound cannot provide. A cold nodule has higher malignancy risk and guides biopsy decisions.
  • Cardiac perfusion imaging: myocardial perfusion SPECT assesses coronary artery disease by measuring blood flow to heart muscle at rest and stress. It provides functional ischaemia information that CT coronary angiography (anatomic) does not directly measure.
  • Infection and osteomyelitis: tagged WBC scans and bone scans detect osteomyelitis and infected hardware with high sensitivity, particularly useful when MRI is limited by metallic implants.
  • Detecting physiologic change before structural change: nuclear medicine detects increased bone turnover, altered perfusion, and metabolic abnormality before CT or MRI shows structural change.

⚠ Consider a different modality when…

  • Detailed anatomic evaluation: CT or MRI provides far better spatial resolution.
  • Whole-body oncologic staging (most cancers): PET/CT has largely superseded conventional nuclear medicine for oncologic staging.
  • Soft tissue, joint, and organ characterisation: MRI superior.
  • Acute emergencies: CT faster and more informative.
+ Technical strengths, limitations & patient preparation

Strengths

  • Evaluates physiology and function — not just structure
  • Whole-body bone scan: highly sensitive for metastatic bone disease
  • Thyroid scan: only study that evaluates nodule function (hot vs. cold)
  • Cardiac perfusion: ischaemia assessment complementing anatomic coronary imaging
  • Detects disease before structural changes appear on CT or MRI

Limitations

  • Lower spatial resolution than CT or MRI
  • Internal radiation from tracer
  • Largely superseded by PET/CT for most oncologic staging indications
  • Some scans require imaging over multiple hours or a second-day scan
  • Non-specific — inflammation also shows increased tracer uptake

📋 Patient Preparation

Preparation varies by study. Bone scan: no special preparation; imaging 2–4 hours after injection. Thyroid scan: thyroid medications and iodine-containing foods/supplements may need to be held. Cardiac studies may require medication holds and supervised stress testing.

Common Indications

Clinical scenarios in which Nuclear Medicine (Bone Scan / SPECT) is typically ordered:

  • Bone metastasis survey in known cancer (breast, prostate, lung)
  • Osteomyelitis evaluation
  • Paget's disease
  • Stress fracture detection
  • Avascular necrosis (alternative to MRI when MRI contraindicated)
  • Thyroid scan for nodule characterization (hot vs. cold)
  • Evaluation of bone pain of uncertain etiology

Contrast Protocols

When to order each protocol for Nuclear Medicine (Bone Scan / SPECT):

Radiotracer Radiotracer injected IV. For bone scan: imaging typically performed 2–4 hours after injection.

Prior Authorization Overview

Typical requirement: Prior auth required. Bone scan for known cancer staging may have less restrictive criteria than non-oncologic indications.

✓ Key Approval Criteria

  • Cancer staging: document cancer type and indication for bone survey
  • Non-oncologic: document clinical indication and why bone scan is preferred over MRI
  • SPECT vs. planar: document why tomographic imaging is needed

⚠ Common Denial Pitfalls

  • Not documenting why bone scan is preferred when MRI would provide equivalent or better information
  • Missing cancer diagnosis code when ordering oncologic bone scan

Frequently Asked Questions

Related Procedures

Need to check authorization for Nuclear Medicine (Bone Scan / SPECT)?

Use Nakod's coverage lookup to verify PA requirements in real time.

Check Coverage →